These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21531257)

  • 1. Artesunate for severe malaria.
    Lancet; 2011 Apr; 377(9776):1466. PubMed ID: 21531257
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
    Noubiap JJ
    J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treating inpatient falciparum malaria on the Thai-Myanmar border.
    Kyaw SS; Drake T; Ruangveerayuth R; Chierakul W; White NJ; Newton PN; Lubell Y
    Malar J; 2014 Oct; 13():416. PubMed ID: 25351915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From quinine to artesunate in Africa.
    Burki T
    Lancet Infect Dis; 2011 Jun; 11(6):428-9. PubMed ID: 21770055
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
    Honrado ER; Fungladda W; Kamoiratanaku P; Kitayaporn D; Karbwang J; Thimasarn K; Masngammueng R
    Bull World Health Organ; 1999; 77(3):235-43. PubMed ID: 10212514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate. The standard intravenous treatment for severe attacks of malaria.
    Prescrire Int; 2014 Nov; 23(154):260. PubMed ID: 25954791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.
    Lubell Y; Riewpaiboon A; Dondorp AM; von Seidlein L; Mokuolu OA; Nansumba M; Gesase S; Kent A; Mtove G; Olaosebikan R; Ngum WP; Fanello CI; Hendriksen I; Day NP; White NJ; Yeung S
    Bull World Health Organ; 2011 Jul; 89(7):504-12. PubMed ID: 21734764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affordable medicines facility for malaria.
    Bate R; Hess K
    Lancet Infect Dis; 2009 Jul; 9(7):396-7. PubMed ID: 19555897
    [No Abstract]   [Full Text] [Related]  

  • 11. Manslaughter by fake artesunate in Asia--will Africa be next?
    Newton PN; McGready R; Fernandez F; Green MD; Sunjio M; Bruneton C; Phanouvong S; Millet P; Whitty CJ; Talisuna AO; Proux S; Christophel EM; Malenga G; Singhasivanon P; Bojang K; Kaur H; Palmer K; Day NP; Greenwood BM; Nosten F; White NJ
    PLoS Med; 2006 Jun; 3(6):e197. PubMed ID: 16752952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
    Newton PN; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
    Clin Infect Dis; 2003 Jul; 37(1):7-16. PubMed ID: 12830403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate v. quinine for severe malaria.
    Naidoo P; Saman S
    S Afr Med J; 2013 May; 103(5):274. PubMed ID: 23971104
    [No Abstract]   [Full Text] [Related]  

  • 14. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 15. Responding to the evidence for the management of severe malaria.
    Ford NP; de Smet M; Kolappa K; White NJ
    Trop Med Int Health; 2011 Sep; 16(9):1085-6. PubMed ID: 21689220
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic biology's first malaria drug meets market resistance.
    Peplow M
    Nature; 2016 Feb; 530(7591):389-90. PubMed ID: 26911755
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa.
    Snow RW; Eckert E; Teklehaimanot A
    Trends Parasitol; 2003 Aug; 19(8):363-9. PubMed ID: 12901938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.